Pangen Biotech Stock Total Debt
| 222110 Stock | KRW 6,000 290.00 4.61% |
PanGen Biotech fundamentals help investors to digest information that contributes to PanGen Biotech's financial success or failures. It also enables traders to predict the movement of PanGen Stock. The fundamental analysis module provides a way to measure PanGen Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PanGen Biotech stock.
PanGen |
PanGen Biotech Company Total Debt Analysis
PanGen Biotech's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current PanGen Biotech Total Debt | 5.49 M |
Most of PanGen Biotech's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PanGen Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, PanGen Biotech has a Total Debt of 5.49 M. This is 99.8% lower than that of the Healthcare sector and 98.31% lower than that of the Biotechnology industry. The total debt for all Republic of Korea stocks is 99.9% higher than that of the company.
PanGen Biotech is the top company in total debt category among its peers. Total debt of Biotechnology industry is presently estimated at about 45.92 Billion. PanGen Biotech adds roughly 5.49 Million in total debt claiming only tiny portion of stocks in Biotechnology industry.PanGen Fundamentals
| Return On Equity | -24.89 | |||
| Return On Asset | -0.079 | |||
| Profit Margin | (0.92) % | |||
| Operating Margin | (0.82) % | |||
| Current Valuation | 90.89 B | |||
| Shares Outstanding | 9.64 M | |||
| Shares Owned By Insiders | 33.33 % | |||
| Shares Owned By Institutions | 2.47 % | |||
| Price To Sales | 13.35 X | |||
| Revenue | 7.94 B | |||
| Gross Profit | 1.35 B | |||
| EBITDA | (3.07 B) | |||
| Net Income | (3.31 B) | |||
| Cash And Equivalents | 8.9 B | |||
| Total Debt | 5.49 M | |||
| Debt To Equity | 1.52 % | |||
| Current Ratio | 1.12 X | |||
| Cash Flow From Operations | (3.32 B) | |||
| Beta | 0.74 | |||
| Market Capitalization | 59.88 B | |||
| Total Asset | 43.28 B | |||
| Net Asset | 43.28 B |
About PanGen Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PanGen Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PanGen Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PanGen Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with PanGen Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PanGen Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PanGen Biotech will appreciate offsetting losses from the drop in the long position's value.Moving against PanGen Stock
| 0.87 | 123040 | MS Autotech CoLtd | PairCorr |
| 0.87 | 101400 | N Citron | PairCorr |
| 0.87 | 122690 | Seojin Automotive CoLtd | PairCorr |
| 0.84 | 012700 | LEADCORP | PairCorr |
| 0.84 | 027710 | FarmStory | PairCorr |
The ability to find closely correlated positions to PanGen Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PanGen Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PanGen Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PanGen Biotech to buy it.
The correlation of PanGen Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PanGen Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PanGen Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PanGen Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in PanGen Stock
PanGen Biotech financial ratios help investors to determine whether PanGen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PanGen with respect to the benefits of owning PanGen Biotech security.